Biotransformation of plant secondary metabolite decursin by mycobacterium sp. PYR1001

Journal of Agricultural and Food Chemistry

Volumn 58, Issue 5, 2010, Pages 2931-2934

  Ki Yeon, K I M ^a   Lee, Sanghyun ^b   Ng Jun, C H A ^a  

^a Department of Biotechnology ^*  (China)

^b Chung Ang University   (South Korea)

Author keywords

Angelica gigas; Biotransformation; Decursin; Decursinol; Mycobacterium

Indexed keywords

BENZOPYRAN DERIVATIVE; BUTYRIC ACID DERIVATIVE; DECURSIN;

ANGELICA; ARTICLE; BIOTRANSFORMATION; METABOLISM; MYCOBACTERIUM;

ANGELICA; BENZOPYRANS; BIOTRANSFORMATION; BUTYRIC ACIDS; MYCOBACTERIUM;

ANGELICA GIGAS; BACTERIA (MICROORGANISMS); MYCOBACTERIUM; MYCOBACTERIUM SP.;

EID: 77949389620     PISSN: 00218561     EISSN: 15205118     Source Type: Journal    
DOI: 10.1021/jf903379c     Document Type: Article

References (27)

1. Sarker, S. D.; Nahar, L. Natural medicine: the genus Angelica. Curr. Med. Chem. 2004, 11, 1479-500.
2. Lee, S.; Kang, S. S.; Shin, K. S. Coumarins and pyrimidine from Angelica gigas roots. Nat. Product Sci. 2002, 8, 58-61.
3. Ahn, M.-J.; Lee, M. K.; Kim, Y. C.; Sung, S. H. The simultaneous determination of coumarins in Angelica gigas root by high performance liquid chromatography-diode array detector coupled with electrospray ionization/mass spectrometry. J. Pharm. Biomed. Anal. 2008, 46, 258-66.
4. Kang, S. Y.; Lee, K. Y.; Sung, S. H.; Kim, Y. C. Four new neuroprotective dihydropyranocoumarins from Angelica gigas. J. Nat. Prod. 2005, 68, 56-9.
5. Lee, S.; Shin, D. S.; Kim, J. S.; Oh, K. B.; Kang, S. S. Antibacterial coumarins from Angelica gigas roots. Arch. Pharm. Res. 2003, 26, 449-52.
6. Jung, M. H.; Lee, S. H.; Ahn, E. -M.; Lee, Y. M. Decursin and decursinol angelate inhibit VEGF-induced angiogenesis via suppression of the VEGFR-2-signaling pathway. Carcinogenesis 2009, 30, 655-61.
7. Ahn, K. S.; Sim, W. S.; Kim, I. H. Decursin: a cytotoxic agent and protein kinase C activator from the root of Angelica gigas. Planta Med. 1996, 62, 7-9.
8. Ahn, K. S.; Sim, W. S.; Lee, I. K.; Seu, Y. B.; Kim, I. H. Decursinol angelate: a cytotoxic and protein kinase C activating agent from the root of Angelica gigas. Planta Med. 1997, 63, 360-1.
9. Lee, S.; Lee, Y. S.; Jung, S. H.; Shin, K. H.; Kim, B. K.; Kang, S. S. Anti-tumor activities of decursinol angelate and decursin from Angelica gigas. Arch. Pharm. Res. 2003, 26, 727-30.
10. Jiang, C.; Guo, J.; Wang, Z.; Xiao, B.; Lee, H.-J.; Lee, E.-O.; Kim, S.-H.; Lu, J. Decursin and decursinol angelate inhibit estrogenstimulated and estrogen-independent growth and survival of breast cancer cells. Breast Cancer Res. 2007, 9, R77.
11. Beibei, H.; Jing, G.; Bo, Y.; Xiaojing, Y.; Lianna, S.; Wansheng, G Heterologous production of secondary metabolites as pharmaceuticals in Saccharomyces cerevisiae. Biotechnol. Lett. 2008, 30, 1121-37.
12. Harvey, A. L. Natural products in drug discovery. Drug Discov. Today 2008, 13, 894-901.
13. Pandey, A.; Benjamin, S; Soccol, C. R.; Nigam, P.; Krieger, N.; Soccol, V. T. The realm of microbial lipases in biotechnology. Biotechnol. Appl. Biochem. 1999, 29, 119-31.
14. Moody, J. D.; Freeman, J. P.; Fu, P. P.; Cerniglia, C. E. Biotransformation of mirtazapine by Cunninghamella elegans. Drug. Metab. Dispos. 2002, 30, 1274-9.
15. Venisetty, R. K.; Ciddi, V. Application of microbial biotransformation for the new drug discovery using natural drugs as substrates. Curr. Pharm. Biotechnol. 2003, 4, 163-7.
16. Lane, D. J. 16S/23S rRNA sequencing. In Nucleic Acid Techniques in Bacterial Systematics; Stackebrandt, E., Goodfellow, M., Eds.; Wiley: Chichester, U.K., 1991; pp 113-175.
17. Bradford, M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of proteindye binding. Anal. Biochem. 1976, 72, 248-54.
18. Kang, S. Y.; Lee, K. Y.; Sung, S. H.; Park, M. J.; Kim, Y. C. Coumarins isolated from Angelica gigas inhibit acetylcholinesterase: structure-activity relationships. J. Nat. Prod. 2001, 64, 683-5.
19. Herath, W.; Reddy, N.; Khan, I. A. Microbial metabolism. Part 8. The pyranocoumarin, decursin. Chem. Pharm. Bull. 2007, 55, 1512-3.
20. Kim, S.; Ko, H.; Son, S.; Shin, K. J.; Kim, D. J. Enantioselective syntheses of (+)-decursinol and (+)-trans-decursidinol. Tetrahedron Lett. 2001, 42, 7641-3.
21. Yim, D.; Singh, R. P.; Agarwal, C.; Lee, S.; Chi, H.; Agarwal, R. A novel anticancer agent, decursin, induces Gl arrest and apoptosis in human prostate carcinoma cells. Cancer Res. 2005, 65, 1035-44.
22. Son, S. H.; Kim, M.-J.; Chung, W.-Y.; Son, J.-A.; Kim, Y. S.; Kim, Y.-C.; Kang, S. S.; Lee, S.-K.; Park, K.-K. Decursin and decursinol inhibit VEGF-induced angiogenesis by blocking the activation of extracellular signal-regulated kinase and c-Jun N-terminal kinase. Cancer Lett. 2009, 280, 86-92.
23. Kang, S. Y.; Kim, Y. C. Decursinol and decursin protect primary cultured rat cortical cells from glutamate-induced neurotoxicity. J. Pharm. Pharmacol. 2007, 59, 863-70.
24. Bae, E.-A.; Han, M. J.; Kim, N.-J.; Kim, D.-H. Anti-Helicobacter pylori activity of herbal medicines. Biol. Pharm. Bull. 1998, 21, 990-2.
25. Lee, H. J.; Lee, H. J.; Lee, E. O.; Lee, J. H.; Lee, K. S.; Kim, K. H.; Kim, S. H.; Lu, J. In vivo anti-cancer activity of Korean Angelica gigas and its major pyranocoumarin decursin. Am. J. Chin. Med. 2009, 37, 127-42.
26. Song, G. Y.; Lee, J. H.; Cho, M.; Park, B. S.; Kim, D. E.; Oh, S. Decursin suppresses human androgen-independent PC3 prostate cancer cell proliferation by promoting the degradation of betacatenin. Mol. Pharmacol. 2007, 72, 1599-606.
27. Nemoto, T.; Ohshima, T.; Shibasaki, M. Enantioselective total syntheses of (+)-decursin and related natural compounds using catalytic asymmetric epoxidation of an enone. Tetrahedron 2003, 59, 6889-97.